Winnow Wealth’s DexCom DXCM Stock Holding History

Winnow Wealth’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1	Closed	-$67	–	253
2025 Q4	$67	Buy	+1	New	+$65	﹤0.01%	573
2025 Q2	–	Sell	-11	Closed	-$720	–	317
2025 Q1	$720	Buy	11 +3	+38%	+$245	﹤0.01%	435
2024 Q4	$554	Buy	+8	New	+$592	﹤0.01%	421

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Winnow Wealth's DXCM Position: Q1 2026 in Review

Winnow Wealth sold out of DexCom (DXCM) in Q1 2026, closing a stake of 1 share — an estimated $67 sold.

Winnow Wealth first reported a position in DXCM in Q4 2024 and held it in 3 quarters. The position peaked at $720 in Q1 2025. 962 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

Winnow Wealth reported no remaining DexCom position as of Q1 2026 after selling out during the quarter.
Winnow Wealth sold 1 DexCom share in Q1 2026, an estimated $67.
Winnow Wealth first reported a position in DexCom in Q4 2024 and held it in 3 quarters.
Winnow Wealth's DexCom position peaked at $720 in Q1 2025.
962 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Winnow Wealth's 13F filing for Q1 2026, filed 19 May 2026.